-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明，無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
Today's biggest pre-market stock movers: 10 top gainers and losers on Tuesday
Today's biggest pre-market stock movers: 10 top gainers and losers on Tuesday
Gainers
$Communications Systems Inc(JCS.US)$ rose 34.8% to $9.15 in pre-market trading as the company declared a special dividend of $3.50 per share.
$DatChat(DATS.US)$ rose 16.2% to $7.60 in pre-market trading after gaining around 4% on Monday.
$Akerna Corp(KERN.US)$ rose 11.5% to $3.69 in pre-market trading. The company agreed to acquire 365 Cannabis, a cannabis business management software system built on Microsoft's Dynamics 365 Business Central in a $17 million deal.
$PainReform Ltd(PRFX.US)$ rose 10.8% to $3.11 in pre-market trading.
$Nanoviricides Inc(NNVC.US)$ rose 10.5% to $4.50 in pre-market trading after the company said it completed licensing for current drug development.
$aTyr Pharma Inc(LIFE.US)$ shares rose 10.3% to $10.09 in pre-market trading. aTyr Pharma shares jumped 67% on Monday after the company announced the Phase 1b/2a clinical trial of ATYR1923 in pulmonary sarcoidosis met its primary endpoint.
$NRX Pharmaceuticals(NRXP.US)$ rose 10% to $12.08 in pre-market trading after IQVIA announced a collaboration with the company on potential medical support for novel treatment.
$CYREN Ltd(CYRN.US)$ rose 9% to $0.6330 in pre-market trading. Cyren and Improving recently reported a partnership to 'strengthen phishing defense for Microsoft 365.'
$Oscar Health, Inc.(OSCR.US)$ rose 9% to $18.64 in pre-market trading. Oscar Health Co-Founder Joshua Kushner reported the purchase of 1,072,264 shares at an average price of $17.41 per share in Form 4 Filing.
$In8bio(INAB.US)$ rose 8.8% to $9.63 in pre-market trading. IN8BIO recently reported a net loss of $1.00 per share for the second quarter, versus a year-ago loss of $0.92 per share.
$Amryt Pharma PLC(AMYT.US)$ rose 7.7% to $11.50 in pre-market trading. Amryt boosted full year 2021 revenue guidance to $220 million - $225 million.
$Ur-Energy Inc(URG.US)$ rose 6.7% to $1.90 in pre-market trading after climbing over 7% on Monday.
$Eyegate Pharmaceuticals Inc(EYEG.US)$ rose 6% to $1.78 in pre-market trading. EyeGate Pharma recently completed target enrollment in Phase 2 proof-of-concept study to evaluate PP-001 for the treatment of ocular surface inflammation.
$Matinas BioPharma Holdings Inc(MTNB.US)$ rose 5.7% to $1.11 in pre-market trading. Matinas BioPharma shares climbed 27% on Monday after the company announced data in the ongoing EnACT trial of MAT2203 for treatment of Cryptococcal Meningitis.
$Markforged Holding Corp(MKFG.US)$ shares rose 5.5% to $8.06 in pre-market trading after dropping 5% on Monday.
Losers
$TMC THE METALS CO INC(TMC.US)$ shares fell 10.8% to $11.10 in pre-market trading after jumping 32% on Monday.
$Renalytix AI PLC(RNLX.US)$ shares fell 7.4% to $21.35 in pre-market trading.
$Old Republic International Corp(ORI.US)$ shares fell 5.5% to $23.73 in pre-market trading.
$Support.com(SPRT.US)$ shares fell 5% to $18.16 in pre-market trading after dropping 9% on Monday. The stock has been circulated as a potential short squeeze candidate on social media.
$Aluminum Corporation Of China(ACH.US)$ fell 5% to $22.09 in pre-market trading after gaining over 8% on Monday.
Gainers
贏家
$Communications Systems Inc(JCS.US)$ rose 34.8% to $9.15 in pre-market trading as the company declared a special dividend of $3.50 per share.
$DatChat(DATS.US)$ rose 16.2% to $7.60 in pre-market trading after gaining around 4% on Monday.
$Akerna Corp(KERN.US)$ rose 11.5% to $3.69 in pre-market trading. The company agreed to acquire 365 Cannabis, a cannabis business management software system built on Microsoft's Dynamics 365 Business Central in a $17 million deal.
$PainReform Ltd(PRFX.US)$ rose 10.8% to $3.11 in pre-market trading.
$Nanoviricides Inc(NNVC.US)$ rose 10.5% to $4.50 in pre-market trading after the company said it completed licensing for current drug development.
$aTyr Pharma Inc(LIFE.US)$ shares rose 10.3% to $10.09 in pre-market trading. aTyr Pharma shares jumped 67% on Monday after the company announced the Phase 1b/2a clinical trial of ATYR1923 in pulmonary sarcoidosis met its primary endpoint.
$NRX Pharmaceuticals(NRXP.US)$ rose 10% to $12.08 in pre-market trading after IQVIA announced a collaboration with the company on potential medical support for novel treatment.
$CYREN Ltd(CYRN.US)$ rose 9% to $0.6330 in pre-market trading. Cyren and Improving recently reported a partnership to 'strengthen phishing defense for Microsoft 365.'
$Oscar Health, Inc.(OSCR.US)$ rose 9% to $18.64 in pre-market trading. Oscar Health Co-Founder Joshua Kushner reported the purchase of 1,072,264 shares at an average price of $17.41 per share in Form 4 Filing.
$In8bio(INAB.US)$ rose 8.8% to $9.63 in pre-market trading. IN8BIO recently reported a net loss of $1.00 per share for the second quarter, versus a year-ago loss of $0.92 per share.
$Amryt Pharma PLC(AMYT.US)$ rose 7.7% to $11.50 in pre-market trading. Amryt boosted full year 2021 revenue guidance to $220 million - $225 million.
$Ur-Energy Inc(URG.US)$ rose 6.7% to $1.90 in pre-market trading after climbing over 7% on Monday.
$Eyegate Pharmaceuticals Inc(EYEG.US)$ rose 6% to $1.78 in pre-market trading. EyeGate Pharma recently completed target enrollment in Phase 2 proof-of-concept study to evaluate PP-001 for the treatment of ocular surface inflammation.
$Matinas BioPharma Holdings Inc(MTNB.US)$ rose 5.7% to $1.11 in pre-market trading. Matinas BioPharma shares climbed 27% on Monday after the company announced data in the ongoing EnACT trial of MAT2203 for treatment of Cryptococcal Meningitis.
$Markforged Holding Corp(MKFG.US)$ shares rose 5.5% to $8.06 in pre-market trading after dropping 5% on Monday.
$通信系統公司(JCS.US)$ 在盤前交易中，該公司股價上漲34.8%，至9.15美元，該公司宣佈派發每股3.50美元的特別股息。
$DatChat(DATS.US)$在週一上漲約4%後，該股在盤前交易中上漲16.2%，至7.60美元。
$Akerna Corp(KERN.US)$在盤前交易中，該股上漲11.5%，至3.69美元。該公司同意以1700萬美元的價格收購365大麻，這是一個基於微軟Dynamics 365商業中心的大麻商業管理軟件系統。
$PainChanging Ltd(PRFX.US)$在盤前交易中，該股上漲10.8%，至3.11美元。
$NanoViricdes Inc.(NNVC.US)$在盤前交易中，該公司上漲10.5%，至4.50美元，此前該公司表示，已完成當前藥物開發的許可。
$aTyr Pharma Inc.(LIFE.US)$在盤前交易中，該公司股價上漲10.3%，至10.09美元。ATyr Pharma股價週一上漲67%，此前該公司宣佈，ATYR1923治療肺結節病的1b/2a期臨牀試驗達到了主要終點。
$NRX製藥公司(NRXP.US)$在IQVIA宣佈與該公司就新療法的潛在醫療支持進行合作後，該公司在盤前交易中上漲10%，至12.08美元。
$CYREN有限公司(CYRN.US)$在盤前交易中，該公司股價上漲9%，至0.6330美元。CyREN和Improving最近報道了一項合作伙伴關係，以加強對微軟365的網絡釣魚防禦。
$Oscar Health，Inc.(OSCR.US)$在盤前交易中，該股上漲9%，至18.64美元。Oscar Health聯合創始人約書亞·庫什納在Form 4文件中報告稱，該公司以每股17.41美元的平均價格購買了1,072,264股票。
$IN8BIO(INAB.US)$在盤前交易中，該股上漲8.8%，至9.63美元。IN8BIO最近公佈第二季度每股淨虧損1.00美元，而去年同期每股虧損0.92美元。
$Amryt Pharma PLC(AMYT.US)$在盤前交易中，該公司股價上漲7.7%，至11.50美元。Amryt將2021年全年收入指引提高到2.2億至2.25億美元。
$Ur-Energy Inc.(URG.US)$在週一攀升逾7%後，該股在盤前交易中上漲6.7%，至1.90美元。
$EyeGate製藥公司(EYEG.US)$在盤前交易中上漲6%，至1.78美元。EyeGate製藥公司最近完成了第二階段概念驗證研究的目標登記，以評估PP-001用於治療眼表炎症的效果。
$Matinas BioPharma Holdings Inc.(MTNB.US)$在盤前交易中，該股上漲5.7%，至1.11美元。Matinas BioPharma股價週一上漲27%，此前該公司宣佈了正在進行的MAT2203治療隱球菌性腦膜炎的ACT試驗數據。
$MarkForge Holding Corp(MKFG.US)$股價在週一下跌5%後，在盤前交易中上漲5.5%，至8.06美元。
Losers
失敗者
$TMC THE METALS CO INC(TMC.US)$ shares fell 10.8% to $11.10 in pre-market trading after jumping 32% on Monday.
$Renalytix AI PLC(RNLX.US)$ shares fell 7.4% to $21.35 in pre-market trading.
$Old Republic International Corp(ORI.US)$ shares fell 5.5% to $23.73 in pre-market trading.
$Support.com(SPRT.US)$ shares fell 5% to $18.16 in pre-market trading after dropping 9% on Monday. The stock has been circulated as a potential short squeeze candidate on social media.
$Aluminum Corporation Of China(ACH.US)$ fell 5% to $22.09 in pre-market trading after gaining over 8% on Monday.
$TMC The Metals Co Inc.(TMC.US)$股價在週一大漲32%後，在盤前交易中下跌10.8%，至11.10美元。
$Renalytix AI PLC(RNLX.US)$在盤前交易中，該公司股價下跌7.4%，至21.35美元。
$舊共和國國際公司(ORI.US)$在盤前交易中，該公司股價下跌5.5%，至23.73美元。
$Support.com(SPRT.US)$股價在週一下跌9%後，在盤前交易中下跌5%，至18.16美元。該股在社交媒體上被認為是潛在的做空候選者。
$中國鋁業(ACH.US)$在週一上漲超過8%的盤前交易中，該公司股價下跌5%，至22.09美元。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國，moomoo上的投資產品和服務由Moomoo Financial Inc.提供，一家受美國證券交易委員會（SEC）監管的持牌主體。 Moomoo Financial Inc.是金融業監管局（FINRA）和證券投資者保護公司（SIPC）的成員。
在新加坡，moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供，該公司受新加坡金融管理局（MAS）監管(牌照號碼︰CMS101000) ，持有資本市場服務牌照 (CMS) ，持有財務顧問豁免（Exempt Financial Adviser）資質。本內容未經新加坡金融管理局的審查。
在澳大利亞，moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供，該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構（AFSL No. 224663）。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件，這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大，透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供，並受加拿大投資監管機構（CIRO）監管。
在馬來西亞，moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供，該公司受馬來西亞證券監督委員會（SC）監管(牌照號碼︰eCMSL/A0397/2024) ，持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.，Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國，moomoo上的投資產品和服務由Moomoo Financial Inc.提供，一家受美國證券交易委員會（SEC）監管的持牌主體。 Moomoo Financial Inc.是金融業監管局（FINRA）和證券投資者保護公司（SIPC）的成員。
在新加坡，moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供，該公司受新加坡金融管理局（MAS）監管(牌照號碼︰CMS101000) ，持有資本市場服務牌照 (CMS) ，持有財務顧問豁免（Exempt Financial Adviser）資質。本內容未經新加坡金融管理局的審查。
在澳大利亞，moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供，該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構（AFSL No. 224663）。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件，這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大，透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供，並受加拿大投資監管機構（CIRO）監管。
在馬來西亞，moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供，該公司受馬來西亞證券監督委員會（SC）監管(牌照號碼︰eCMSL/A0397/2024) ，持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.，Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能，分享給你的好友吧